How many email patterns does Io Therapeutics use?

Io Therapeutics uses 1 known email pattern.

What domain does Io Therapeutics use for work emails?

Io Therapeutics uses io-therapeutics.com for work email addresses.

Most Common Email Formats at Io Therapeutics

Io Therapeutics's most common email format is FLast@io-therapeutics.com (ex. JDoe@io-therapeutics.com), used for 100% of io-therapeutics.com addresses. Io Therapeutics uses 1 email pattern.

@io-therapeutics.com

1 pattern

Format	Example	Share of io-therapeutics.com
FLast@io-therapeutics.comMost common	JDoe@io-therapeutics.com	100%

Need a specific person's email?

Browse Io Therapeutics's employee directory (about 3 employees) and reveal verified emails free.

Frequently Asked Questions

What does Io Therapeutics do?

Io Therapeutics operates in the Biotechnology Research industry, alongside similar companies like Regeneron, Roche and Bristol Myers Squibb. You can visit io-therapeutics.com or contact Io Therapeutics's headquarters by phone at

+1-650-219-****

. Explore Io Therapeutics's company overview page for more information.

What is Io Therapeutics's email address format?

Io Therapeutics's email format typically follows the pattern of FLast@io-therapeutics.com; this email format is used 100% of the time. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Io Therapeutics have currently?

Io Therapeutics has approximately 3 employees as of November 2026. Key team members to contact include Co-Founder, Board Member, Cso, Io Therapeutics; Https:/Io-Therapeutics.Com: S. V. For more team information and contact data, explore Io Therapeutics's employee directory with LeadIQ.

Io Therapeutics Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Io Therapeutics is a small biotechnology company based in Santa Ana, California. Its research focuses on cancer, including the development of an anti-cancer compound called IRX4204 and investigations into its effects on human multiple myeloma. The organization participates in collaborative research with academic partners to advance its science.

In December 2025 Io Therapeutics presented preclinical data at the American Society for Hematology Annual Meeting showing synergistic efficacy when BCMA CAR-T cells are used in combination with IRX4204 against human multiple myeloma. In March 2026 the company announced a collaboration with Duke University and a publication in Scientific Reports detailing studies on IRX4204 and its impact on multiple myeloma.

Most common format

FLast@io-therapeutics.com

Example: JDoe@io-therapeutics.com

1 pattern. See all formats

Verify a Io Therapeutics email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Io Therapeutics

@io-therapeutics.com

Need a specific person's email?

Frequently Asked Questions

What does Io Therapeutics do?

What is Io Therapeutics's email address format?

How many employees does Io Therapeutics have currently?

Io Therapeutics Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.